NEW YORK, July 19, 2016 /PRNewswire/ --
Stock-Callers.com has initiated coverage on the following equities: Aetna Inc. (NYSE: AET), Anthem Inc. (NYSE: ANTM), WellCare Health Plans Inc. (NYSE: WCG), and Nobilis Health Corp. (NYSE MKT: HLTH). Learn more about these stocks by accessing their free trade alerts at:
The Healthcare sector encompasses a broad range of companies that provide products and offer services essential for the growing population. Despite cost pressures and policy risks, the industry presents various opportunities for growth. Stock-Callers.com takes a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions. Register with us now for your free membership and more at:
On Monday, Hartford, Connecticut-based Aetna Inc.'s stock recorded a trading volume of 2.30 million shares and ended the session 0.23% lower at $118.36. The Company's shares have gained 7.37% in the previous three months and 10.22% since the start of this year. The stock is trading 1.59% above its 50-day moving average and 7.68% above its 200-day moving average. Moreover, shares of Aetna, which operates as a health care benefits company in the U.S., have a Relative Strength Index (RSI) of 52.00.
On July 01st, 2016, Reuters reported that Aetna has launched an auction to divest a portfolio of Medicare Advantage assets as it continues to pursue antitrust approval for its $37 billion acquisition of U.S. health insurance peer Humana Inc. The company is hoping the move will help ease antitrust concerns. Merging Aetna's and Humana's Medicare Advantage businesses would make the combined company the largest U.S. manager of the healthcare insurance for seniors and the disabled. The assets will likely be valued around the $1 billion range, as per the report. See our complete notes on AET at:
Indianapolis, Indiana headquartered Anthem Inc.'s stock closed the day 0.51% higher at $135.00 and with a total volume of 1.06 million shares traded. The Company's shares have advanced 2.06% in the past month. The stock is trading 2.02% above its 50-day moving average and 0.11% above its 200-day moving average. Additionally, shares of Anthem, which through its subsidiaries, operates as a health benefits company in the U.S., have an RSI of 58.69.
On June 30th, 2016, Bloomberg reported that the U.S. Department of Justice has told Anthem that its $48 billion planned acquisition of Cigna Corp. threatens competition and probably cannot be resolved by selling parts of their businesses. The report stated that The Justice Department has indicated that it is open to hearing about proposals from the company to resolve the problems. The complimentary note on ANTM can be accessed on at:
WellCare Health Plans
Shares in Tampa, Florida headquartered WellCare Health Plans Inc. recorded a trading volume of 294,386 shares at the close of the last trading session. The stock ended 0.20% higher at $109.07. The Company's shares have advanced 3.48% in the past month, 19.05% over the previous three months, and 39.46% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 6.67% and 22.74%, respectively. Furthermore, shares of WellCare Health Plans, which provides managed care services for government-sponsored health care programs, have an RSI of 63.39.
On June 27th, 2016, WellCare Health Plans announced the appointment of Karen M. Johnson as chief operating officer of its Easy Choice Health Plan, which is based in California, effective the same day. Ms, Karen will report to Kelly Munson, WellCare's senior vice president, division president, and Medicaid product. Register for free and access key note on WCG at:
Houston, Texas headquartered Nobilis Health Corp.'s stock finished Monday's session 1.27% higher at $2.39 with a total volume of 138,575 shares traded. The Company's shares have advanced 0.84% in the last month. The stock is trading below its 50-day moving average by 12.22%. Additionally, shares of Nobilis Health, which together with its subsidiaries, acquires and manages ambulatory surgical centers and healthcare facilities in the U.S., have an RSI of 48.84.
On July 11th, 2016, Nobilis Health Corp. announced that it has named Kenneth Efird as President, with immediate effect. As President, Mr. Efird, will have responsibility for all of the Company's operating units nationally and will continue to focus on executing the Company's strategic plan. He will report directly to Chief Executive Officer, Harry Fleming. Mr. Efird, who joined Nobilis Health in 2005, has earlier served as Chief Operating Officer and Chief Business Development Officer of the Company. Notes are available for free at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA